Scientists present that lecanemab clears amyloid plaques by partaking microglia by its Fc fragment, defining the mobile program behind its therapeutic impact Lecanemab, marketed as Leqembi, is a monoclonal antibody therapy for Alzheimer’s illness that reduces the buildup of poisonous amyloid plaques within the mind and slows cognitive decline. Scientists from VIB and KU Leuven […]
Source link
A brand new nanoparticle-based strategy improved motion in a mouse mannequin of Parkinson’s illness. The approach might ultimately supply a extra versatile different to standard deep mind stimulation....
Read more
